UnitedHealth Group Stock Holds Near $373 After Q2 Earnings
UnitedHealth Group's stock price held steady near $373 after the company released its Q2 earnings report, despite falling short of its 52-week high. On September 22, 2026, the stock closed at $372.80 on the NYSE, down 1.26 percent from the previous session.
The company's revenue reached $112.03 billion in Q2 2026, exceeding analyst expectations of $110.81 billion. Adjusted earnings per share (EPS) also beat consensus estimates, coming in at $6.38, compared to $4.94 and $4.08 in the same quarter last year.
UnitedHealth Group set fiscal-year 2026 adjusted EPS guidance at $19.50 to $20.00, with an average analyst rating of Moderate Buy and a price target of $456.56. The stock's market capitalization stood at $334.758 billion as of September 23, 2026.
The company's Q2 earnings report showed a modest recovery test after the second-quarter update, with the stock still trading below its yearly high of $461.62. However, the price remains above the annual low of $256.00 recorded on March 28, 2026.